This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation: A Randomized Controlled Trial—Correction

JAMA. 2006;296:1355.

Additional Study Group Member: In the Original Contribution entitled "Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation: A Randomized Controlled Trial" published in the July 5, 2006, issue of JAMA (2006;296:56-63), the following name should appear. On page 63, under the Varenicline Phase 3 Study Group, "Raymond Niaura, PhD, Transdisciplinary Research, Butler Hospital, Providence, RI" should appear at the end of the list.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?